Pegfilgrastim Injection

Product Description

Pegfilgrastim is a medication used to stimulate the production of white blood cells, specifically neutrophils, in patients undergoing chemotherapy. Neutropenia, a condition characterized by a low level of neutrophils, is a common side effect of chemotherapy and can increase the risk of infections.

The typical dosage of pegfilgrastim for preventing chemotherapy-induced neutropenia is a single injection of 6 mg administered subcutaneously (under the skin). This injection is usually given 24 hours after the completion of chemotherapy to help boost the production of neutrophils and reduce the risk of infection.

It's important to follow your healthcare provider's instructions regarding the timing and administration of pegfilgrastim injections. They will tailor the dosage and schedule based on your specific chemotherapy regimen and medical condition. Additionally, they will monitor your blood cell counts regularly to ensure that the treatment is effective and adjust the dosage if necessary.